Objective To explore differences in blood cytokine profiles among distinct bronchopulmonary dysplasia (BPD) patterns. Study design We evaluated blood spots collected from 943 infants born at ≤1000 g and surviving to 28 days on postnatal days 1, 3, 7, 14, and 21 for 25 cytokines. Infants were assigned to the following lung disease patterns: (1) no lung disease (NLD); (2) respiratory distress syndrome without BPD; (3) classic BPD (persistent exposure to supplemental oxygen until 28 days of age); or (4) atypical BPD (period without supplemental oxygen before 28 days). Median cytokine levels for infants with BPD were compared with the IQR of results among infants with NLD. Results The distribution of enrolled infants by group was as follows: 69 (NLD), 73 (respiratory distress syndrome), 381 (classic BPD), and 160 (atypical BPD). The remaining 260 infants could not be classified because of missing data (104) or not fitting a predefined pattern (156). Median levels of 3 cytokines (elevated interleukin [IL]-8, matrix metalloproteinase-9; decreased granulocyte macrophage colony-stimulating factor) fell outside the IQR for at least 2 time points in both infants with atypical and classic BPD. Profiles of 7 cytokines (IL-6, IL-10, IL-18, macrophage inflammatory protein-1α, C-reactive protein, brain-derived neurotrophic factor, regulated on activation, normal T cell expressed and secreted) differed between infants with classic and atypical BPD. Conclusions Blood cytokine profiles may differ between infants developing classic and atypical BPD. These dissimilarities suggest the possibility that differing mechanisms could explain the varied patterns of pathophysiology of lung disease in extremely premature infants.
|Journal||Journal of Pediatrics|
|State||Published - Jul 1 2016|
Bibliographical noteFunding Information:
The Neonatal Research Network's Cytokines Study was supported by the National Institutes of Health (NIH; M01 RR30 , M01 RR32 , M01 RR39 , M01 RR70 , M01 RR80 , M01 RR633 , M01 RR750 , M01 RR997 , M01 RR6022 , M01 RR7122 , M01 RR8084 , M01 RR16587 ), the NICHD ( U01 HD36790 , U10 HD21364 , U10 HD21373 , U10 HD21385 , U10 HD21397 , U10 HD21415 , U10 HD27851 , U10 HD27853 , U10 HD27856 , U10 HD27871 , U10 HD27880 , U10 HD27881 , U10 HD27904 , U10 HD34216 , U10 HD40461 , U10 HD40492 , U10 HD40498 , U10 HD40689 ), and the Centers for Disease Control and Prevention (CDC; Interagency Agreement Y1-HD-5000-01). C.D. is supported by NICHD (1 U10 HD 068263). Participating sites collected data and transmitted it to RTI International, the data coordinating center for the network, which stored, managed, and analyzed the data for this study. Although NICHD and CDC staff did have input into the study design, conduct, analysis, and manuscript drafting, the content is solely the responsibility of the authors and does not necessarily represent the official views of NICHD or CDC. The authors declare no conflicts of interest.
© 2016 Elsevier Inc.
- chronic lung disease
- inflammatory markers
- premature infant
- respiratory distress syndrome
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health